Education
Pulmonologists as the Gatekeepers of Precision Medicine
Array
Activity Info
Presented by: Momen M. Wahidi, MD, FCCP and W. Dean Wallace, MDBiomarker-driven targeted therapy of patients with NSCLC requires accurate diagnosis and staging. The pulmonary care team must acquire adequate biopsy tissue to enable histology, immunofluorescence and molecular biomarker testing.
Presented in Los Angeles, California - October 2016.
Digital Download
Pulmonologists as the Gatekeepers of Precision Medicine: How Much is Enough Tissue?
This activity is a downloadable file. You must add it to your course history to access the file. Click
